A Composite Ovine Forestomach Matrix and Hyaluronic Acid CAMP for the Treatment of Full Thickness Wounds of the Foot in People With Diabetes: A Randomized Controlled Trial
Eine zusammengesetzte ovine Forestomach Matrix und Hyaluronsäure CAMP zur Behandlung von Vollhautwunden am Fuß bei Menschen mit Diabetes: randomisierte kontrollierte Studie
International Wound Journal · 2026-10 · 23 (10)
DOI: 10.1111/iwj.71056 ↗Auf einen Blick
Bei Menschen mit diabetesbedingten Fußwunden heilten unter OFM-HA plus SOC nach 12 Wochen mehr Wunden als unter SOC allein. Die Studie berichtet keine unerwarteten Sicherheitsereignisse.
Fragestellung
Verbessert OFM-HA plus SOC im Vergleich zu SOC allein die Heilung chronischer Vollhautwunden am Fuß bei Menschen mit Diabetes?
Methode
Prospektive multizentrische kontrollierte Studie; 143 randomisiert; Vergleich OFM-HA plus SOC vs. SOC allein; primärer Endpunkt: verheilte Wunden nach 12 Wochen.
Ergebnisse
Modified-intent-to-treat: 46 % (31/68) unter OFM-HA plus SOC vs. 24 % (17/72) unter SOC allein; p = 0,008. Kaplan-Meier zugunsten OFM-HA plus SOC; log-rank p = 0,023.
Einschränkungen
Post-randomization exclusions, differierender Studienabbruch und eine adjustierte Analyse nahe der Signifikanzgrenze (p = 0,045).
Schlussfolgerung der Autor:innen
OFM-HA plus SOC erhöhte die 12-Wochen-Verschlussrate in dieser ausgewählten Population.
Kernaussagen
- 12-Wochen-Heilung: 46 % vs. 24 %
- Kein unerwartetes Sicherheitsereignis beobachtet
- Interpretation durch Ausschlüsse und Dropouts limitiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Wound Journal, online erschienen am 01.10.2026. Verfasst von David G Armstrong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Diabetic Foot, Hyaluronic Acid, Wound Healing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Aroa Biosurgery Limited.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetic foot ulcers (DFUs) are a devastating complication of diabetes that markedly affects quality of life and generates significant socioeconomic and healthcare burdens. When DFUs fail to respond to standard of care (SOC), advanced therapies including Cellular, Acellular and Matrix‐like Products (CAMPs) are often employed. A novel composite CAMP comprising ovine forestomach matrix and high molecular weight hyaluronic acid, termed ‘OFM‐HA’ has been developed for the treatment of chronic wounds and evaluated in a prospective multi‐centre controlled trial. For this trial, 143 subjects were randomized to receive OFM‐HA plus SOC or SOC alone for the treatment of chronic full thickness wounds of the foot in people with diabetes meeting prespecified eligibility criteria. The primary endpoint was the proportion of wounds healed by 12 weeks. Secondary endpoints included healing time, percentage area reduction, adverse events and changes in pain and quality of life. For the modified intent‐to‐treat population, 46% (31/68) of the OFM‐HA plus SOC group healed by 12 weeks compared to 24% (17/72) in the SOC alone group ( p = 0.008). Kaplan–Meier analysis favoured OFM‐HA plus SOC over 12 weeks (log‐rank p = 0.023). No unexpected safety‐related occurrences were observed. OFM‐HA plus SOC increased 12‐week closure in this selected population. Interpretation is limited by post‐randomization exclusions, differential withdrawal and an adjusted comparison close to the significance threshold ( p = 0.045).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
- Division of Plastic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Division of Plastic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Surgery, Drexel University School of Medicine, Philadelphia, Pennsylvania, USA.
- Center for Clinical Research, Castro Valley, California, USA.
ORCID-Profile: David G Armstrong, Robert D Galiano, John C Lantis, Paul Glat, Adam L Isaac, Marissa J Carter, Charles M Zelen
Förderung
- Aroa Biosurgery Limited
Zitieren
APA
Armstrong, D. G., Orgill, D. P., Galiano, R. D., Lantis, J. C., Glat, P., Reyzelman, A. M., Snyder, R. J., Isaac, A. L., Carter, M. J., & Zelen, C. M. (2026). A Composite Ovine Forestomach Matrix and Hyaluronic Acid CAMP for the Treatment of Full Thickness Wounds of the Foot in People With Diabetes: A Randomized Controlled Trial. International Wound Journal, 23(10). https://doi.org/10.1111/iwj.71056
Vancouver
Armstrong DG, Orgill DP, Galiano RD, Lantis JC, Glat P, Reyzelman AM, et al. A Composite Ovine Forestomach Matrix and Hyaluronic Acid CAMP for the Treatment of Full Thickness Wounds of the Foot in People With Diabetes: A Randomized Controlled Trial. International Wound Journal. 2026;23(10). doi:10.1111/iwj.71056
BibTeX
@article{Armstrong2026,
author = {Armstrong, David G and Orgill, Dennis P and Galiano, Robert D and Lantis, John C and Glat, Paul and Reyzelman, Alexander M and Snyder, Robert J and Isaac, Adam L and Carter, Marissa J and Zelen, Charles M},
title = {A Composite Ovine Forestomach Matrix and Hyaluronic Acid CAMP for the Treatment of Full Thickness Wounds of the Foot in People With Diabetes: A Randomized Controlled Trial},
journal = {International Wound Journal},
year = {2026},
volume = {23},
number = {10},
doi = {10.1111/iwj.71056}
}
EUVIMED